Latest on Pharmaceutical Industry


Roche receives EU approval for Gazyvaro, European approval for Actemra

Roche said it has received European approval for its Actemra medication in giant cell arteritis (GCA), the Swiss drugmaker said on Friday. “As the first effective non-steroid therapy for GCA, Actemra/RoActemra has t..Read More...

Juno Therapeutics Opens New Headquarters and Research Center

Juno Therapeutics, Inc., a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today unveiled its new headquarters and research facility, located in the heart of South La..Read More...



Analytica Anacon India & India Lab Expo 2017

Hitex, Hyderabad,
MMI India Pvt. Ltd.


Baltmedica 2017

Lithuanian Exhibition and Congress Center LiTEXPO,

Press Releases

Avara Pharmaceutical Services acquires Consumer Healthcare facility from GSK in Aiken, South Carolina

Avara Pharmaceutical Services has signed an agreement with GSK to acquire a GSK consumer healthcare manufacturing facility in Aiken South Carolina This acquisition is an important component of our strategic plan and expa.. Read More...

Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo® 32mg Extended Release Tablets

Perrigo Company plc announced it has received final approval from the US Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Exalgo 32mg extended release tablets hydromorphone HCl T.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Bayer Pharmaceuticals

Bayer Pharmaceuticals Christoph Huwe PhD CAAM is a Strategic Alliance Manager Therapeutics at Bayer AG Pharmaceuticals with a focus on the BayerEvotec Endometriosis BayerEvotec Kidney Diseases BayerOncoMed Oncology strategic alliances and the Tuberculosis Drug Accelerator consortium He is also a member of Bayers Alliance. Read More...
Christoph Huwe
Strategic Alliance Manager Therapeutics